Preliminary results of the Japanese Encephalitis Vaccination via IntraDermal route trial (JEVID)

Japanese Encephalitis (JE) is the leading cause of viral encephalitis in Asia. Until the 2022 JE outbreak, the only known locally transmitted human cases of JE in Australia occurred in 1995 on Badu Island in the Torres Strait, and in 1998 on Badu Island and the Cape York Peninsula. In Australia, JE was predominantly a ‘travellers’ disease’.

UQ, QIMR Berghofer and Brisbane-based clinic Dr Deb the Travel Doctor are conducting a collaborative clinical trial to investigate the immunogenicity of fractional dosing to reduce the cost of JE vaccines to sufficiently increase uptake among travellers. 

The speaker will:

• showcase preliminary trial results
• discuss implications of mass vaccination programs in the event of a larger Australian JE outbreak discuss the use of fractional vaccine doses.  

You're welcome to join our Zoom seminar on 25 May from 12pm to 12.30pm. No registration required.

Watch the recorded seminar

Watch the recording (YouTube 29m:7s)

About our speaker

Dr Luis Furuya-Kanamori is an NHMRC early career fellow and clinical epidemiologist at the UQ Centre for Clinical Research. His research focuses on providing evidence for more efficient use of vaccines and medications in travellers, and developing and refining research synthesis methods.